Olive Lifesciences Publishes Coleus Review

Olive Lifesciences published a review article on the benefits and safety of coleus in the Journal of Oriental Pharmacy and Experimental Medicine.

October 13, 2014

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

BENGALURU, India—Olive Lifesciences published a review article on benefits and safety of coleus in the Journal of Oriental Pharmacy and Experimental Medicine.

The review describes well-established food and traditional use of coleus, its phytochemical information, biological effects and coleus safety assessment in both animals and humans. The published review covers up to date ethnopharmacological, phytochemical and pharmacological information of Coleus forskohlii, approaching toward its safety and therapeutic perspective.

Currently, Victoria University (Melbourne, Australia) is evaluating appetite suppressant properties associated with Olive’s Coleus forskohlii extract in overweight and obese individuals of Australian population. Victoria University is the primary sponsor of the study.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like